Last reviewed 2026-04-20 · How we verify
NVP-2002 is a small molecule drug in Phase 1 development by NVP Healthcare. It has completed one trial assessing its pharmacokinetic characteristics and safety. No FDA label or approved indications are available.
No approved indications tracked.
No common side effects on file.